electronic trial master file (eTMF)
What is a Trial Master File?
Clinical trials help establish the safety and effectiveness of medical interventions in patients. A Trial Master File contains all the documents pertaining to a specific trial. This often includes the study protocol, management plan, investigator brochure, informed consent forms, monitoring reports, and much more.
What is an Electronic Trial Master File (eTMF)?
An Electronic Trial Master File (eTMF) is any software solution that enables storage and management of essential documents and data for clinical trials. A robust eTMF allows sponsors to not only quickly visualize clinical trial progress and manage study documents, but also abide by good clinical practices (GCP).
Five Main Benefits of using an eTMF
Maximize Efficiency
Streamline the trial process by facilitating document filing in accordance with the latest reference model. By improving the searchability and traceability of study documents,...
Read MoreMaximize Efficiency
Streamline the trial process by facilitating document filing in accordance with the latest reference model. By improving the searchability and traceability of study documents, clinical teams can save critical time and improve internal processes.
Read LessGather Insights
View planned and actual milestones at any given point during the study. eTMFs often offer reports and dashboards, which aid in identifying potential problems early on and tracking...
Read MoreGather Insights
View planned and actual milestones at any given point during the study. eTMFs often offer reports and dashboards, which aid in identifying potential problems early on and tracking trial progress.
Read LessEnhance Collaboration
Sponsors, CROs, and site staff are seldom based in the same location. Teams spread across different time zones can leverage built-in tools such as workflows and document editors...
Read MoreEnhance Collaboration
Sponsors, CROs, and site staff are seldom based in the same location. Teams spread across different time zones can leverage built-in tools such as workflows and document editors to collaborate both asynchronously and simultaneously. A centralized eTMF reduces reliance on multiple communication methods out of the system; instead, instructions and comments provided within the eTMF are considered the source of truth. These capabilities cut down on miscommunications and rework.
Read LessImprove Inspection Readiness
Ensure documents are present and filed correctly in accordance with the latest regulations. If a sponsor has dozens of sites at various stages within the same trial, the... Read MoreImprove Inspection Readiness
Ensure documents are present and filed correctly in accordance with the latest regulations. If a sponsor has dozens of sites at various stages within the same trial, the eTMF can be updated contemporaneously, which provides a clearer picture which documents are outstanding. Read LessControl TMF Security
TMFs often contain sensitive information, some of which must be blinded for study personnel. eTMFs provide more advanced access permissions than traditional shared drives, which... Read MoreControl TMF Security
TMFs often contain sensitive information, some of which must be blinded for study personnel. eTMFs provide more advanced access permissions than traditional shared drives, which protects patients and the integrity of the trial data. Read LessTrial Master File (TMF) FAQs
Adopting an eTMF solution is no simple feat. We’ve compiled some frequently asked questions about eTMFs.
What is the tangible impact of an effective eTMF?
The benefits of a well-implemented eTMF span far beyond your organization’s clinical team. Consider the following scenarios:
- Leadership plans to discuss highly anticipated trials during the quarterly town hall. The eTMF enables them to access trial information more readily.
- Clinical Research Associates (CRAs) use eTMF to remotely access the ISF. By doing so, CRAs can shorten site visits and save department costs.
- Legal needs to reference trial information that may be involved in litigation. Before the eTMF was implemented, files were often edited with little visibility into who made what change. Now, the eTMF System Administrator may place a hold on documents, ensuring no users are versioning or deleting it.
Which eTMF systems are popular?
There are numerous eTMF vendors in the life sciences space, all of which generally provide reporting, workflow automation, and document version control. We’ve listed some of the most well-known software below.
- Egnyte eTMF (Egnyte): Based on the CDISC TMF Reference Model. Allows for streamlined data collection across study sites and from other sources, such as eISF or CTMS.
- eTMF Manager (MasterControl): Based on DIA Reference Model. eTMF Manager features external collaboration and task assignment that links accountable users to specific artifacts.
- Rave eTMF (Medidata, Dassault Systemes): Allows ease of collaboration between sponsor, CRO, and site systems. Rave eTMF may be implemented in eight weeks and auto-populates content if integrated with Rave EDC and Rave CTMS.
- Trial Interactive eTMF (TransPerfect): AI-powered eTMF that can be connected to TI’s 21 CFR Part 11 Compliant eClinical Platform. Unique features include document redaction, correspondence inbox, and a mobile application.
- Vault eTMF (Veeva Systems): A cloud-based application, Vault eTMF has been adopted by 450+ organizations and can be integrated within Veeva’s Clinical Suite (EDC, CTMS, Study Startup, Site Connect). Vault eTMF allows customization across most features.
What are important considerations when selecting an eTMF solution?
When deciding among eTMF vendors, gather the following information about your organization.
- Business Requirements: eTMF solutions are not one-size-fits-all. Determine which features are nice-to-have, and which ones are critical for your organization. For example, if 21 CFR Part 11 eSignatures in the eTMF and email correspondence capture are must-haves, confirm that potential vendors will support those needs.
- Budget: eTMFs should be viewed as an investment. Licensing, professional services, and subscription fees may be continuing costs that should be compared against your department's budget. Ask sales reps how pricing may change as you add more studies and scale the organization.
- Timeline: Consider each vendor’s proposed implementation timeline against the time constraints of your company. If your first study site activation is in two months, narrow consideration down to vendors who can complete the project in that timeframe.
- Complexity: Adopting an eTMF is an investment not only of money, but also of time and effort. Is the system easy to use? Can users be quickly onboarded and instructed on conducting processes within the eTMF? It is important to factor in your team’s adaptability and appetite for change when implementing a particular solution.
ProPharma's TMF Services & Approach
Thanks to eTMF, paper-based processes have become obsolete. For many sponsors, however, the current challenge lies in correctly using eTMFs to prevent avoidable delays and garner actionable insights. ProPharma's R&D Technology team understands the implications of selecting the right eTMF and excels in aligning your companies' needs with regulations and GxP system best practices. Our comprehensive approach and expert knowledge ensure that your organization is set up for long-term success. Our team has extensive experience in the following areas:
Service Category |
How We Can Help |
Strategy & Business Process Optimization |
|
Clinical Operations |
|
Implementation Support |
|
Validation |
|
Managed Services |
|
ProPharma's eTMF Expertise
If you are interested in implementing or optimizing eTMF, ProPharma's R&D Technology team comprises experienced consultants who can advise your digital transformation. If you are interested in partnering with ProPharma on any of the services above, contact us via the form below. We look forward to working with you!
News & Insights
December 19, 2024
WHO Issues Guidance on Antibiotic Pollution Control
WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.
December 18, 2024
Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding
Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
September 24, 2024
ProPharma Honored in the 2024 Clinical Trials Excellence Awards
ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.
June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights
December 18, 2024
Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding
Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.